Congress Asset Management Co. Has $106.44 Million Stake in The Cooper Companies, Inc. (NASDAQ:COO)

Congress Asset Management Co. cut its stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 7.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,157,876 shares of the medical device company's stock after selling 89,308 shares during the period. Congress Asset Management Co. owned approximately 0.58% of Cooper Companies worth $106,444,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently added to or reduced their stakes in COO. Figure 8 Investment Strategies LLC acquired a new position in Cooper Companies during the 4th quarter worth approximately $1,360,000. Buckhead Capital Management LLC lifted its position in shares of Cooper Companies by 0.3% in the fourth quarter. Buckhead Capital Management LLC now owns 48,120 shares of the medical device company's stock worth $4,424,000 after purchasing an additional 152 shares in the last quarter. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new position in Cooper Companies during the fourth quarter worth $691,000. Entropy Technologies LP bought a new position in Cooper Companies in the fourth quarter valued at $248,000. Finally, Empowered Funds LLC increased its stake in Cooper Companies by 15.2% in the 4th quarter. Empowered Funds LLC now owns 3,556 shares of the medical device company's stock valued at $327,000 after buying an additional 470 shares during the last quarter. Institutional investors own 24.39% of the company's stock.

Cooper Companies Stock Performance

Shares of NASDAQ:COO traded down $0.83 on Wednesday, hitting $86.46. The company had a trading volume of 5,215,625 shares, compared to its average volume of 1,448,122. The stock has a market cap of $17.26 billion, a price-to-earnings ratio of 44.34, a P/E/G ratio of 2.23 and a beta of 1.00. The stock has a 50 day moving average price of $93.48 and a 200 day moving average price of $99.74. The Cooper Companies, Inc. has a 1-year low of $84.76 and a 1-year high of $112.38. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, beating analysts' consensus estimates of $1.00 by $0.04. The business had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.03 billion. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. Cooper Companies's quarterly revenue was up 9.8% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.87 EPS. Analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Analysts Set New Price Targets

A number of equities analysts have recently commented on COO shares. Citigroup reduced their price objective on shares of Cooper Companies from $116.00 to $115.00 and set a "buy" rating for the company in a research note on Friday, December 6th. Morgan Stanley decreased their price target on Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating for the company in a research note on Friday, December 6th. Wells Fargo & Company upped their price objective on Cooper Companies from $115.00 to $118.00 and gave the stock an "overweight" rating in a research note on Friday, December 6th. Needham & Company LLC reissued a "hold" rating on shares of Cooper Companies in a report on Friday, December 6th. Finally, StockNews.com downgraded shares of Cooper Companies from a "buy" rating to a "hold" rating in a report on Wednesday, December 11th. Three analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Cooper Companies presently has a consensus rating of "Moderate Buy" and a consensus target price of $117.00.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.